Quarterly report pursuant to Section 13 or 15(d)

NATURE OF BUSINESS AND ORGANIZATION (Details)

v3.23.1
NATURE OF BUSINESS AND ORGANIZATION (Details) - USD ($)
1 Months Ended 3 Months Ended
Sep. 30, 2022
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Accumulated deficit       $ 179,499,043
Net loss     $ 6,139,797  
Fixed asset impairment charges   $ 0    
Uninsured cash balances   12,200,000   $ 19,400,000
Cancer treatment research award through the National Cancer Institute (NCI)        
Grant amount   $ 2,000,000.0    
Grant period   3 years    
Grant received $ 1,980,000 $ 406,000    
Leasehold Improvements [Member]        
Property and equipment useful lives   64 months    
Minimum [Member]        
Share-based compensation expiration period   1 year    
Property and equipment useful lives   3 years    
Maximum [Member]        
Share-based compensation expiration period   3 years    
Property and equipment useful lives   10 years